H. Gholizadeh

In silico and in vitro drug repurposing strategy for targeting dopamine receptor D2 in colorectal Cancer treatment

Background Colorectal cancer (CRC) remains a major global health burden due to its high incidence, mortality, and therapy resistance. Drug repurposing offers a promising approach to identify new treatments using approved drugs with known safety profiles. This study evaluates the potential of targeting dopamine receptor...